Victrex plc Share Price

Equities

VCT

GB0009292243

Specialty Chemicals

Market Closed - London S.E. 16:35:23 17/07/2024 BST 5-day change 1st Jan Change
1,110 GBX +0.36% Intraday chart for Victrex plc 0.00% -27.07%

Financials

Sales 2024 * 297M 386M 29.66B Sales 2025 * 320M 416M 31.98B Capitalization 965M 1.26B 96.52B
Net income 2024 * 37M 48.12M 3.7B Net income 2025 * 62M 80.63M 6.2B EV / Sales 2024 * 3.27 x
Net Debt 2024 * 3.92M 5.1M 392M Net cash position 2025 * 20.25M 26.34M 2.03B EV / Sales 2025 * 2.96 x
P/E ratio 2024 *
30.8 x
P/E ratio 2025 *
15.4 x
Employees 1,109
Yield 2024 *
5.4%
Yield 2025 *
5.58%
Free-Float 98.37%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.36%
Current month-3.14%
1 month-3.48%
3 months-11.62%
6 months-18.86%
Current year-27.07%
More quotes
1 week
1 072.00
Extreme 1072
1 156.00
1 month
1 072.00
Extreme 1072
1 224.00
Current year
1 072.00
Extreme 1072
1 545.00
1 year
1 072.00
Extreme 1072
1 632.00
3 years
1 072.00
Extreme 1072
2 700.00
5 years
1 072.00
Extreme 1072
2 720.00
10 years
1 072.00
Extreme 1072
3 438.06
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 31/08/17
Director of Finance/CFO - -
Director of Finance/CFO - 03/07/22
Members of the board TitleAgeSince
Chief Executive Officer 60 31/08/17
Chairman 64 30/11/21
Director/Board Member 68 08/02/18
More insiders
Date Price Change Volume
17/07/24 1,110 +0.36% 113,311
16/07/24 1,106 -0.54% 80,935
15/07/24 1,112 -2.97% 62,326
12/07/24 1,146 +0.53% 92,122
11/07/24 1,140 +2.70% 132,926

Delayed Quote London S.E., July 17, 2024 at 04:35 pm

More quotes
Victrex plc is a United Kingdom-based holding company. The principal activity of the Company is the manufacture and sale of high-performance polymers. The Company develops solutions in polyetheretherketone (PEEK) and polyaryletherketone (PAEK) based polymers and selects semi-finished and finished parts. The Company operates through two segments: Sustainable Solutions and Medical. The Sustainable Solutions segment focuses on its energy and industrial, value-added resellers (VAR), automotive, aerospace and electronics markets. The Medical segment is focused on providing specialist solutions for medical device manufacturers. The Company’s subsidiaries include Victrex Manufacturing Limited, Invibio Limited, Invibio Knees Limited, Invibio Device Component Manufacturing Limited and Juvora Limited.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
11.1 GBP
Average target price
13.83 GBP
Spread / Average Target
+24.57%
Consensus